ImmunoHorizons is a fully peer-reviewed open access, online-only journal committed to advancing the knowledge of immunology. All editorial decisions are made by practicing scientists. ImmunoHorizons is an open access journal; copyright is held by the authors. During submission, the corresponding author will, on behalf of all authors, select a license type under which the article will be published. AAI offers a choice of the following licenses:
- CC BY 4.0 (Creative Commons Attribution 4.0 International License)
- CC BY-NC 4.0 (Creative Commons Attribution-NonCommercial 4.0 International License)
- CC BY-NC-ND 4.0 (Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License)
The author(s) retain copyright of all material published in ImmunoHorizons, unless all authors are employees of the US Government, in which case the article is in the public domain in the United States. If all authors are employees of the US Government, the article will be published under a CC BY 4.0 license.
Criteria for publication include rigorous methodology with well supported conclusions that advance the field and are of broad interest. ImmunoHorizons will consider observations of interest even if complete mechanistic or functional characterization cannot yet be provided. ImmunoHorizons will also consider for publication novel methods, assays or computational tools, as well as initial characterizations of novel reagents, including mouse strains, clones and antibodies, even if biological insights have not yet been fully realized. Large descriptive data sets which are of interest to the field will also be considered.
Research Articles
Work from across the full spectrum of the immunology landscape will be considered. Research articles will be published in the following sections:
- Adaptive Immunity
- Clinical and Translational Immunology
- Infectious Disease
- Innate Immunity
On the Horizon
ImmunoHorizons will publish invited commentaries focused on future directions in a specific area of immunology research. The articles should be 4-6 journal pages in length, including illustrations and references. Articles should provide succinct overviews of a research area but should maintain a focus "on the horizon," with the goal of highlighting current gaps in knowledge and major unanswered questions. Speculation is encouraged.
Journal Facts
- Publisher: ImmunoHorizons (IH) is owned and published by The American Association of Immunologists, Inc.
- Editor-in-Chief: Mark H. Kaplan, Ph.D.
- Editorial Board: ImmunoHorizons Editorial Board. All Editors are practicing scientists.
- The Staff: ImmunoHorizons Staff Members
- Online ISSN 2573-7732
Contact information
ImmunoHorizons
The American Association of Immunologists, Inc.
1451 Rockville Pike, Suite 650
Rockville, MD 20852
Phone: 301-634-7197
Fax: 301-246-8401
Email: infoih@aai.org
AAI Disclaimer
THIS WEBSITE IS PROVIDED ON AN "AS IS" AND "AS AVAILABLE" BASIS, WITHOUT WARRANTIES OR REPRESENTATIONS OF ANY KIND (EXPRESS, IMPLIED OR STATUTORY, INCLUDING BUT NOT LIMITED TO WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE), ALL OF WHICH THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, INC., DISCLAIMS TO THE FULLEST EXTENT PERMITTED BY LAW.
In no event shall The American Association of Immunologists, Inc., be liable for any special, incidental, indirect or consequential damages of any kind, or any damages whatsoever resulting from loss of use, data or profits, whether or not advised of the possibility of damage, and on any theory of liability, arising out of or in connection with the use or performance of this information.
The ideas and opinions expressed in ImmunoHorizons do not necessarily reflect those of The American Association of Immunologists, Inc., or the Editors or staff of ImmunoHorizons.
The American Association of Immunologists, Inc., neither endorses nor takes responsibility for any products, goods or services offered by outside vendors through its services or advertisements.
Your use of the site is at your sole risk and by use of this site you agree that the exclusions and limitations of liability in this Disclaimer are reasonable.